HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tom Haverty Selected Research

ELX-02

1/2021A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tom Haverty Research Topics

Disease

1Cystic Fibrosis (Mucoviscidosis)
01/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2021

Drug/Important Bio-Agent (IBA)

1ELX-02IBA
01/2021
1Nonsense Codon (Nonsense Mutation)IBA
01/2021

Therapy/Procedure

1Therapeutics
01/2021